Peel Hunt Begins Coverage on Horizon Discovery (LON:HZD)

Peel Hunt initiated coverage on shares of Horizon Discovery (LON:HZD) in a report issued on Tuesday, March 20th. The brokerage issued a hold rating and a GBX 181 ($2.56) price objective on the stock.

Other research analysts also recently issued research reports about the stock. Numis Securities reissued a buy rating and set a GBX 300 ($4.24) target price on shares of Horizon Discovery in a research note on Tuesday, February 20th. N+1 Singer dropped their price objective on shares of Horizon Discovery from GBX 250 ($3.53) to GBX 230 ($3.25) and set a buy rating for the company in a research note on Monday, February 19th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company has a consensus rating of Buy and an average target price of GBX 226.83 ($3.21).

How to Become a New Pot Stock Millionaire

LON HZD traded up GBX 1.50 ($0.02) on Tuesday, reaching GBX 144 ($2.04). 70,823 shares of the company’s stock traded hands, compared to its average volume of 258,981. Horizon Discovery has a fifty-two week low of GBX 160 ($2.26) and a fifty-two week high of GBX 294 ($4.16).

In related news, insider Susan Galbraith acquired 70,000 shares of the firm’s stock in a transaction dated Monday, February 5th. The shares were purchased at an average cost of GBX 179 ($2.53) per share, for a total transaction of £125,300 ($177,102.47). Also, insider Jonathan Milner bought 90,492 shares of Horizon Discovery stock in a transaction on Wednesday, February 7th. The shares were acquired at an average price of GBX 165 ($2.33) per share, for a total transaction of £149,311.80 ($211,041.41). In the last three months, insiders bought 834,492 shares of company stock valued at $125,549,180.

COPYRIGHT VIOLATION NOTICE: “Peel Hunt Begins Coverage on Horizon Discovery (LON:HZD)” was reported by Macon Daily and is the sole property of of Macon Daily. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece of content can be accessed at

About Horizon Discovery

Horizon Discovery Group plc, a life science company, engages in precision gene editing to design, build, and apply cells to advance human health worldwide. Its core capabilities are built around its proprietary transnational genomics platform, a suite of gene editing tools, such as rAAV, ZFN, and CRISPR to alter gene sequence in human or mammalian cell-lines.

Analyst Recommendations for Horizon Discovery (LON:HZD)

Receive News & Ratings for Horizon Discovery Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery and related companies with's FREE daily email newsletter.

Leave a Reply